Dallas, TX, United States of America

Robert M Dowben

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Baylor Research Institute, Organ Transport Pty Ltd, Organ Transport Systems, Inc.. Active years: 1980-2026.

USPTO Granted Patents = 10 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.9

ph-index = 7

Forward Citations = 188(Granted Patents)


Location History:

  • Dallas, TX (US) (1980 - 1996)
  • Providence, RI (US) (2004 - 2024)

Company Filing History:


Years Active: 1980-2026

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Robert M Dowben

Introduction: Robert M Dowben, a pioneering inventor based in Dallas, Texas, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Robert M Dowben holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: With a career spanning over two decades, Robert M Dowben has established himself as a leading figure in the innovation landscape. His work has been recognized for its ingenuity and practical applications in improving everyday life.

Collaborations: Throughout his career, Robert M Dowben has collaborated with top research institutions, leading companies, and innovative startups to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge technologies that have reshaped industries.

Conclusion: Robert M Dowben's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor. His work continues to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…